研究简要摘要： 本研究为一项前瞻性、随机、假对照、三盲试验，探讨将个人化alpha神经回馈（NF）结合认知训练（Cogmed）能否改善儿童脑肿瘤存活者（PBTS）的认知功能；此族群在癌症治疗后有持续认知困难的风险。
适应症：Brain Tumor, Primary
入组条件
纳入标准
- \- Paediatric brain tumour survivors aged 6 to 18 years
- Completion of primary cancer treatment (for example, surgery, chemotherapy, or radiotherapy) at least six months prior
- Documented or reported cognitive difficulties in attention or executive functioning
- Ability and willingness to attend scheduled sessions over four weeks
排除标准
- \- Severe neurological or psychiatric conditions (for example, uncontrolled seizures) that preclude EEG monitoring or completing computer-based training
- Medication regimens that significantly interfere with EEG signals and cannot be safely adjusted
- Severe sensory or motor deficits that would make training infeasible
- Inability or unwillingness to follow study protocol
入组条件维持 ClinicalTrials.gov 原始英文登记资料，实际入组资格以研究团队的正式评估与受试者知情同意书为准。资料来源：ClinicalTrials.gov，每两周自动更新，最后同步：2026年10月8日。